Testosterone supplementation versus clomiphene citrate for hypogonadism

An age matched comparison of satisfaction and efficacy

Ranjith Ramasamy, Jason M. Scovell, Jason R. Kovac, Larry I. Lipshultz

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Purpose We compared satisfaction and treatment efficacy in men with symptomatic hypogonadism who received clomiphene citrate or testosterone supplementation therapy. Materials and Methods Men treated with clomiphene citrate, or testosterone injections or gels for symptomatic hypogonadism (total testosterone less than 300 ng/dl) reported satisfaction with the current treatment regimen using the qADAM questionnaire. Results A total of 93 men on testosterone injections (31) or gels (31), or clomiphene citrate (31) were age matched from a retrospective cohort of 1,150 on testosterone supplementation therapy. We compared men who received testosterone supplementation therapy to 31 not on such therapy, who served as controls. Median serum testosterone increased from pretreatment levels in all men regardless of therapy with clomiphene citrate, and testosterone injections and gels (from 247 to 504, 224 to 1,104 and 230 to 412 ng/dl, respectively, p 0.05). Men receiving testosterone injections reported greater libido than men on clomiphene citrate (4 vs 3, p = 0.04) or testosterone gels (4 vs 3, p = 0.04), or controls (4 vs 3, p

Original languageEnglish (US)
Pages (from-to)875-879
Number of pages5
JournalJournal of Urology
Volume192
Issue number3
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Clomiphene
Hypogonadism
Testosterone
Gels
Injections
Therapeutics
Libido

Keywords

  • clomiphene
  • hypogonadism
  • questionnaires
  • testes
  • testosterone

ASJC Scopus subject areas

  • Urology

Cite this

Testosterone supplementation versus clomiphene citrate for hypogonadism : An age matched comparison of satisfaction and efficacy. / Ramasamy, Ranjith; Scovell, Jason M.; Kovac, Jason R.; Lipshultz, Larry I.

In: Journal of Urology, Vol. 192, No. 3, 2014, p. 875-879.

Research output: Contribution to journalArticle

@article{805e02d477c2448e8870ecf0596e379d,
title = "Testosterone supplementation versus clomiphene citrate for hypogonadism: An age matched comparison of satisfaction and efficacy",
abstract = "Purpose We compared satisfaction and treatment efficacy in men with symptomatic hypogonadism who received clomiphene citrate or testosterone supplementation therapy. Materials and Methods Men treated with clomiphene citrate, or testosterone injections or gels for symptomatic hypogonadism (total testosterone less than 300 ng/dl) reported satisfaction with the current treatment regimen using the qADAM questionnaire. Results A total of 93 men on testosterone injections (31) or gels (31), or clomiphene citrate (31) were age matched from a retrospective cohort of 1,150 on testosterone supplementation therapy. We compared men who received testosterone supplementation therapy to 31 not on such therapy, who served as controls. Median serum testosterone increased from pretreatment levels in all men regardless of therapy with clomiphene citrate, and testosterone injections and gels (from 247 to 504, 224 to 1,104 and 230 to 412 ng/dl, respectively, p 0.05). Men receiving testosterone injections reported greater libido than men on clomiphene citrate (4 vs 3, p = 0.04) or testosterone gels (4 vs 3, p = 0.04), or controls (4 vs 3, p",
keywords = "clomiphene, hypogonadism, questionnaires, testes, testosterone",
author = "Ranjith Ramasamy and Scovell, {Jason M.} and Kovac, {Jason R.} and Lipshultz, {Larry I.}",
year = "2014",
doi = "10.1016/j.juro.2014.03.089",
language = "English (US)",
volume = "192",
pages = "875--879",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Testosterone supplementation versus clomiphene citrate for hypogonadism

T2 - An age matched comparison of satisfaction and efficacy

AU - Ramasamy, Ranjith

AU - Scovell, Jason M.

AU - Kovac, Jason R.

AU - Lipshultz, Larry I.

PY - 2014

Y1 - 2014

N2 - Purpose We compared satisfaction and treatment efficacy in men with symptomatic hypogonadism who received clomiphene citrate or testosterone supplementation therapy. Materials and Methods Men treated with clomiphene citrate, or testosterone injections or gels for symptomatic hypogonadism (total testosterone less than 300 ng/dl) reported satisfaction with the current treatment regimen using the qADAM questionnaire. Results A total of 93 men on testosterone injections (31) or gels (31), or clomiphene citrate (31) were age matched from a retrospective cohort of 1,150 on testosterone supplementation therapy. We compared men who received testosterone supplementation therapy to 31 not on such therapy, who served as controls. Median serum testosterone increased from pretreatment levels in all men regardless of therapy with clomiphene citrate, and testosterone injections and gels (from 247 to 504, 224 to 1,104 and 230 to 412 ng/dl, respectively, p 0.05). Men receiving testosterone injections reported greater libido than men on clomiphene citrate (4 vs 3, p = 0.04) or testosterone gels (4 vs 3, p = 0.04), or controls (4 vs 3, p

AB - Purpose We compared satisfaction and treatment efficacy in men with symptomatic hypogonadism who received clomiphene citrate or testosterone supplementation therapy. Materials and Methods Men treated with clomiphene citrate, or testosterone injections or gels for symptomatic hypogonadism (total testosterone less than 300 ng/dl) reported satisfaction with the current treatment regimen using the qADAM questionnaire. Results A total of 93 men on testosterone injections (31) or gels (31), or clomiphene citrate (31) were age matched from a retrospective cohort of 1,150 on testosterone supplementation therapy. We compared men who received testosterone supplementation therapy to 31 not on such therapy, who served as controls. Median serum testosterone increased from pretreatment levels in all men regardless of therapy with clomiphene citrate, and testosterone injections and gels (from 247 to 504, 224 to 1,104 and 230 to 412 ng/dl, respectively, p 0.05). Men receiving testosterone injections reported greater libido than men on clomiphene citrate (4 vs 3, p = 0.04) or testosterone gels (4 vs 3, p = 0.04), or controls (4 vs 3, p

KW - clomiphene

KW - hypogonadism

KW - questionnaires

KW - testes

KW - testosterone

UR - http://www.scopus.com/inward/record.url?scp=84906098883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906098883&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2014.03.089

DO - 10.1016/j.juro.2014.03.089

M3 - Article

VL - 192

SP - 875

EP - 879

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 3

ER -